Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. News>
  4. Page 16

CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

  • Post published:June 1, 2026
  • Post category:News

The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…

Continue Reading CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know

  • Post published:May 28, 2026
  • Post category:News

The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…

Continue Reading US 100% Pharma Tariff Spares Indian Generics — What Buyers and Exporters Need to Know

CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre

  • Post published:May 26, 2026
  • Post category:News

India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…

Continue Reading CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre

India Supplies 20% of Global Generic Medicines, GTRI Confirms IP Rules WTO-Compliant

  • Post published:May 24, 2026
  • Post category:News

New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released…

Continue Reading India Supplies 20% of Global Generic Medicines, GTRI Confirms IP Rules WTO-Compliant
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve